Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Cash generated from core business operations
Latest
$-70.30M
↓ 108% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-33.77M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-70.30M | +3.9% |
| 2024 | $-73.19M | -19.5% |
| 2023 | $-61.27M | -91.0% |
| 2022 | $-32.08M | -67.6% |
| 2021 | $-19.13M | -124.3% |
| 2020 | $-8.53M | +61.0% |
| 2019 | $-21.88M | -149.3% |
| 2018 | $-8.78M | +0.1% |
| 2017 | $-8.79M | - |